Skip to main content
. Author manuscript; available in PMC: 2009 Aug 7.
Published in final edited form as: Paediatr Perinat Epidemiol. 2009 Mar;23(2):171–184. doi: 10.1111/j.1365-3016.2008.00985.x

Table 2.

Screening visit blood and urine sample collection

Collection tube
(anticoagulant) (no.
tubes × volume)
Specimen type No. of
aliquots × volume
Test to be performed Method Test lab
Red top (Glassa) (No
  anticoagulant) (2 × 10 mL)
Serum 2×5mL Extra stored serum
Lavendar top (EDTA)
  (1×3 mL)
Whole blood 3 mL Heavy metals AAS and ICP-MS CDC
Red top (no anticoagulant)
  (1 × 10 mL)
Serum 1 × 1.1 mL CMP and total cholesterol ACA Kaleida
Serum 1 × 1.1 mL Chlamydia IgG screen Serology Kalieda
Serum 1 × 0.6 mL Extra stored
Urine Spot urine 7 × 4.0 mL Extra stored
a

Glass tubes used for trace elements and/or environmental toxins.

AAS, atomic absorption spectroscopy; ACA, automated chemistry analysis; CMP, complete metabolic profile; ICP, inductively coupled plasma mass spectroscopy; CDC, Centers for Disease Control, Atlanta, Georgia; Kaleida Health Laboratories, Buffalo, New York State.